FDA Approves Once-Weekly Sogroya for Children With Turner Syndrome
Novo Nordisk's Sogroya becomes the first long-acting growth hormone approved in the U.S. for pediatric patients with Turner syndrome,…
Novo Nordisk's Sogroya becomes the first long-acting growth hormone approved in the U.S. for pediatric patients with Turner syndrome,…